Skip to main navigation Skip to search Skip to main content

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants with Huntington's Disease

Project: Research

Project Details

StatusFinished
Effective start/end date06/6/22 → 07/31/25

Funding

  • Sage Therapeutics Incorporated: $101,622.62